GLP-1 weight loss drugs show 37% to 68% greater hair loss risk
A new study of about 50,000 people found that GLP-1 agonist drugs, like Ozempic and Wegovy, are linked to a higher risk of hair loss. Researchers at the University of Pennsylvania Health System discovered that GLP-1 drugs carried a 37% to 68% greater risk of alopecia when contrasted with other diabetes medications. The UK's MHRA has received hundreds of hair loss reports for these drugs.
Lost in this story? That's the point of BriefTea.
Open it in the app and tap Learn from this — the Knowledge Galaxy turns the story into a map of everything it assumes you know, one tap at a time. Free, no ads, no paywall.
Get BriefTea on the App Store